跳至主要内容
临床试验/2023-503220-76-01
2023-503220-76-01招募中4 期

Prednisolone administration in women with unexplained REcurrent MIscarriages

Leiden University Medical Center12 个研究点 分布在 1 个国家目标入组 490 人开始时间: 2023年10月5日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
490
试验地点
12
主要终点
Last study subject has completed last visit and all data is gathered

研究概览

简要总结

The primary aim of the PREMI trial is to assess the effect of prednisolone administration during early pregnancy in women with unexplained recurrent miscarriages in comparison to the use of a placebo, specifically focusing on the live birth rate as the primary outcome measure.

研究设计

分配方式
Randomized
主要目的
Prednisolone administration in women with REcurrent MIscarriages
盲法
Double (Carer, Subject, Investigator, Analyst)

入排标准

年龄范围
18 years 至 64 years(18-64 Years)
性别
Female
接受健康志愿者
是

入选标准

  • •Two or more miscarriages (mola and ectopic pregnancies excluded)
  • •No underlying cause was found for miscarriages after examination

排除标准

  • •Diabetes with medication
  • •Previous enrollment/ participation in PREMI trial
  • •Contraindication for the use of glucocorticosteroids
  • •Use of medication that interferes with prednisolone (see protocol for list)
  • •Instable or exacerbation of auto-immune disease
  • •Use of immune suppressing medication (for any reason)
  • •Participation or enrollment in other interventional trial for recurrent miscarriages

结局指标

主要结局

Last study subject has completed last visit and all data is gathered

Last study subject has completed last visit and all data is gathered

次要结局

  • DSMB advises to stop trial (for feasibility, slow inclusion rate, safety concerns etc.)

研究者

发起方
Leiden University Medical Center
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Department of gynecology and obstetrics

Scientific

Leiden University Medical Center

研究点 (12)

Loading locations...

相似试验